NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

52 hedge funds and large institutions have $7.5M invested in Navidea Biopharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 2 closing their positions.

Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
10
Closed
2
Calls
$30K
Puts
$43K
Net Calls
-$13K
Net Calls Change
+$38K

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$172K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$193K
3
Jane Street
3
Jane Street
New York
$76K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.49M
5
TRCT
5
Tower Research Capital (TRC)
New York
$25K

Top Sellers

1
BlackRock
1
BlackRock
New York
$1.27M
2
Millennium Management
2
Millennium Management
New York
$156K
3
SIM
3
Spark Investment Management
New York
$180K
4
Goldman Sachs
4
Goldman Sachs
New York
$152K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$22K
Name Holding Trade Value Shares
Change 		Shares
Change %
CPIG
51
Chicago Partners Investment Group
Illinois
– -$2K -174 Closed
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -45 Closed
1 2
3